Security National Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.6K Hold
1,294
0.01% 211
2026
Q1
$78.5K Hold
1,294
0.01% 202
2025
Q4
$69.8K Hold
1,294
0.01% 204
2025
Q3
$58.4K Hold
1,294
0.01% 236
2025
Q2
$59.9K Buy
1,294
+87
+7% +$4.27K 0.01% 207
2025
Q1
$73.6K Hold
1,207
0.01% 185
2024
Q4
$68.3K Buy
+1,207
New +$67.4K 0.01% 187
2018
Q3
Sell
-50,815
Closed -$2.81M 65
2018
Q2
$2.81M Buy
50,815
+3,022
+6% +$163K 1.79% 27
2018
Q1
$3.02M Sell
47,793
-1,141
-2% -$73.4K 2.02% 17
2017
Q4
$3M Sell
48,934
-150
-0.3% -$9.38K 1.95% 21
2017
Q3
$3.13M Buy
49,084
+853
+2% +$49.8K 2.14% 15
2017
Q2
$2.69M Buy
48,231
+1,967
+4% +$107K 1.96% 21
2017
Q1
$2.52M Buy
+46,264
New +$2.54M 1.88% 22

Other funds holding BMY

Security National Bank's BMY Position: Q2 2026 in Review

Security National Bank held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1,294 shares worth $74.6K. The position accounts for 0.01% of the portfolio, ranked #211.

Security National Bank first reported a position in BMY in Q1 2017 and has held it in 13 quarters since. The position peaked at $3.13M in Q3 2017. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Security National Bank held 1,294 shares of Bristol-Myers Squibb worth $74.6K as of Q2 2026.
  • Security National Bank left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Security National Bank's portfolio in Q2 2026, its #211 holding.
  • Security National Bank first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 13 quarters since.
  • Security National Bank's Bristol-Myers Squibb position peaked at $3.13M in Q3 2017.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Security National Bank's 13F filing for Q2 2026, filed 15 Jul 2026.